/COMUNICAE/
SPIMACO is a leading Saudi laboratory in the pharmaceutical market, specialized in the sale of pharmaceutical products and medical devices. Enzymax Forte is the most successful product of AORA Health worldwide, using dual-release technology in stomach and intestine for a faster and more complete effect
AORA Health, a Spanish pharmaceutical laboratory specializing in the development of high-value nutraceutics, has partnered with the Saudi market leader SPIMACO to launch ENZYMAX Forte in Saudi Arabia, with the common goal of becoming a key actor in the digestive category, through an exclusive distribution agreement.
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO Addwaeih) is a society established in 1986. Its main business is a doctor and pharmacist and includes the development, manufacture and sale of pharmaceuticals and medical devices. The company has a strong position in Saudi Arabia and to attend export markets, as it has a presence in 12 international markets.
ENZYMAX Forte is the most successful product of AORA Health globally. It contains 8 digestive enzymes of microbial origin, one of the widest and most complete compositions on the market, which help digest all major food groups (grasses, proteins and carbohydrates).
Its technology is based on a double selective release of digestive enzymes in the stomach and intestine, which increases its effectiveness.
Them digestive products developed by AORA Health they are differentiated by their high efficiency and by having a broad objective, which is directed both to the digestive process in the stomach and the intestine. In addition, the technology developed by AORA allows to direct, specifically and selectively, the enzymes, either in the stomach or in the intestine, in their optimal conditions of performance.
According to Gonzalo Peñaranda, CEO of AORA Health: “Our digestive products are present in more than 20 markets. Our objective is to offer efficient and scientifically proven products that contribute to the health and well-being of people, consolidating and growing our digestive range in the Saudi market, among others.”
Source Comunicae
AORA Health joins SPIMACO and launches Enzymax Forte in Saudi Arabia
SPIMACO is a leading Saudi laboratory in the pharmaceutical market, specialized in the sale of pharmaceutical products and medical devices. Enzymax Forte is th
nails
en
https://nails-trends.com/static/images/nails-aora-health-joins-spimaco-and-launches-enzymax-forte-in-saudi-arabia-836-0.jpg
2024-09-23
Acording with the Digital Millennium Copyright Act (“DMCA”), Pub. L. 105-304 If you believe that your copyrighted work is being infringed, notify our team at the email bitelchux@yahoo.es